Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
Mohan A, Tiwari P, Suri TM, Mittal S, Patel A, Jain A, Velpandian T, Das US, Boppana TK, Pandey RM, Shelke SS, Singh AR, Bhatnagar S, Masih S, Mahajan S, Dwivedi T, Sahoo B, Pandit A, Bhopale S, Vig S, Gupta R, Madan K, Hadda V, Gupta N, Garg R, Meena VP, Guleria R.
.
Cancer Sci. 2021 Sep 10. doi: 10.1111/cas.15131. Online ahead of print. Cancer Sci. 2021. PMID: 34506683 Free article.
.
N Engl J Med. 2021 Sep 9;385(11):1018-1032. doi: 10.1056/NEJMra2101555. N Engl J Med. 2021. PMID: 34496176 Review.
.